Eradication of Helicobacter pylori in routine clinical practice: Doubts and uncertainties

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 312-315

  Cammarota, Giovanni ^a,b   Cianci, Rossella ^a   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Clinical practice; H. pylori; Therapy

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; OMEPRAZOLE; PROTON PUMP INHIBITOR; TINIDAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; FEMALE; GASTROSCOPY; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; STOMATITIS; VOMITING;

ADULT; AGED; AMBULATORY CARE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTITRICHOMONAL AGENTS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MACROLIDES; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; TINIDAZOLE; TREATMENT OUTCOME;

EID: 0033067545     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1 Patchett S, Beattie S, Leen E, et al: Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 1992; 87:24-27.
2. 2 Rokkas T, Karameris A, Mavrogeorgis A, et al: Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41:1-4.
3. 3 Jaspersen D, Koerner T, Schorr W, et al: Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41:5-7.
4. 4 Cammarota G, Tursi A, Montalto M, et al: Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-Hp therapy. J Clin Gastroenterol 1995; 21(2):118-122.
5. 5 Labenz J, Borsch G: Towards an optimal treatment of Helicobacter pylori-positive peptic ulcers. Am J Gastroenterol 1995; 90:692-694.
6. 6 De Boer WA, Tytgat GNJ: The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995; 30:401-407.
7. 7 Bazzoli F, Zagari RM, Fossi S, et al: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol, 1994; 6:773-777.
8. 8 Lind T, Veldhuyzen Van Zanten SJO, Unge P, et al: The MACH1 study: optimal one-week treatment for H. pylori defined? Gut 1995; 37(Suppl 1):A4.
9. 9 Cutler AF, Schubert TT: Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993; 88:505-509.
10. 10 Laine L, Stein C, Neil G: Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing optional dosing. Am J Gastroenterol 1995; 90:1407-1410.
11. 11 Tursi A, Cammarota G, Montalto M, et al: Low-dose Omeprazole plus Clarithromycin and either Tinidazole or Amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 19(3):285-288.
12. 12 Tytgat GNJ, Axon ATR, Dixon MF, et al: Helicobacter pylori: causal agent in peptic ulcer disease? In: Working Party reports; 9th World Congress of Gastroenterology, 26-31 August, Sydney, Australia, 1990. Oxford: Blackwell Scientific Publications, 1990; pp. 36-40.
13. 13 Penston JG, Minstry KR: Eradication of Helicobacter pylori in general practice. Aliment Pharmacol Ther 1996; 10:139-145.
14. 14 Jaup BH, Norrby A: Low-dose short-term triple therapy for eradication of Helicobacter pylori. Am J Gastroenterol, 1994; 89:1400. (Abstract)
15. 15 Buiatti E, Munoz N, Vivas J, et al: Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes and Control 1994; 5:249-254.
16. 16 Olson C, Edmonds A: Primary susceptibility of H. pylori to clarithromycin compared to metronidazole in patients with duodenal ulcers associated with H. pylori infection. Gut 1995; 37(Suppl 2):A814.
17. 17 Craft JC, Olson C, Siepman N, et al: Clarithromycin resistance in U.S. and European patients treated with clarithromycin and omeprazole for duodenal ulcer disease associated with Helicobacter pylori infection. Gut 1995; 37(Suppl 2):A816.
18. 18 DeCross AJ, Marshall BJ, McCallum RW, et al: Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol 1993; 31:1971-1974.
19. 19 Xia HX, Gilvarry J, Beattie S, et al: Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol 1995; 90:1221-1225.
20. 20 Bell GD, Powell KU, Burridge SM, et al: Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993; 86:375-382.
21. 21 de Boer W, Ziekenhuis SA, Tytgat G: Helicobacter pylori eradication and reinfection. Lancet 1995; 245:1647-1648.
22. 22 Tursi A, Cammarota G, Montalto M, et al: The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. Am J Gastroenterol 1996; 91(4):817-818.